Brief: Biosyent extends in-license agreement for cathejell
20/04/2017 21:00
April 20 (Reuters) - Biosyent Inc RX.V :
* Biosyent extends in-license agreement for cathejell(r)
* Biosyent Inc - extended its license, distribution and
supply agreement with its European partner, Pharmazeutische
Fabrik Montavit GES.M.B.H.
* Extensio gives Biosyent Pharma exclusive Canadian rights
to cathejell jelly 2 pct product until march 31, 2024
Source text for Eikon: ID:nCCN5VWHPr
Further company coverage: RX.V
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid